Raymond James Financial Inc. Invests $716,000 in Alpha Teknova, Inc. (NASDAQ:TKNO)

Raymond James Financial Inc. bought a new position in Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 85,779 shares of the company's stock, valued at approximately $716,000. Raymond James Financial Inc. owned about 0.16% of Alpha Teknova as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in TKNO. China Universal Asset Management Co. Ltd. bought a new stake in Alpha Teknova during the fourth quarter worth approximately $94,000. Whalen Wealth Management Inc. bought a new position in Alpha Teknova during the fourth quarter valued at $240,000. State Street Corp increased its position in Alpha Teknova by 249.3% during the third quarter. State Street Corp now owns 76,645 shares of the company's stock valued at $371,000 after acquiring an additional 54,700 shares during the last quarter. Nkcfo LLC bought a new stake in shares of Alpha Teknova in the 4th quarter worth about $501,000. Finally, Geode Capital Management LLC boosted its stake in shares of Alpha Teknova by 24.4% during the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company's stock worth $911,000 after purchasing an additional 36,914 shares during the period. 13.81% of the stock is currently owned by hedge funds and other institutional investors.

Alpha Teknova Trading Down 5.6 %

TKNO stock traded down $0.32 during midday trading on Thursday, reaching $5.41. The company's stock had a trading volume of 635,251 shares, compared to its average volume of 344,478. Alpha Teknova, Inc. has a 1 year low of $1.16 and a 1 year high of $10.37. The firm has a market capitalization of $289.09 million, a price-to-earnings ratio of -7.31 and a beta of 0.54. The stock has a fifty day simple moving average of $6.46 and a two-hundred day simple moving average of $7.00. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last posted its quarterly earnings results on Tuesday, March 4th. The company reported ($0.11) EPS for the quarter. The company had revenue of $9.27 million during the quarter, compared to analysts' expectations of $9.10 million. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. On average, equities research analysts predict that Alpha Teknova, Inc. will post -0.58 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Craig Hallum started coverage on shares of Alpha Teknova in a research note on Monday, February 10th. They issued a "buy" rating and a $12.00 price objective for the company.

Alpha Teknova Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.